RISHP 15th Annual Future of Pharmacy Showcase

Rhode Island Society of Health-System Pharmacists Future of Pharmacy Showcase

Pharmacists and Pharmacy Technicians

4.0 Contact Hours (0.4 CEUs)

October 19, 2019

Crowne Plaza Hotel

801 Greewich Ave, Warwick, RI 02886

7:00 am: Registration, Breakfast, and Exhibitor Displays

7:45 am: Opening Remarks

8:00 am: Ray Iannuccillo, PharmD, MBA, BCPS, BCOP Oncology Investigational Pharmacist, Rhode Island Hospital, “Rhode Island Hospital's Approach to Improve Patient Safety and Optimize Pharmacy Services for Patients on Clinical Trials”

8:30 am: Linda Nelson, PharmD, BCCCP, FASHP, Women & Infants Hospital, “Oral Compared to Intravenous Antibiotics for Preterm Pre-labor Rupture of Membranes”

9:00 am: Ann Marie Broccolo, CPhT, Pharmacy Technician, Westerly Hospital, China Bergeron, CPhT, CSPT, Pharmacy Technician, Lawrence & Memorial Hospital, Caralyn Granato, PharmD Candidate 2021, University of Rhode Island,"New Career Trends for Pharmacy Technicians"

09:30 am: Karen Nolan, RPh, Pharmacy Manager, Rhode Island Hospital & Mark Rogers, PharmD, MBA, CDOE, CVDOE, Director of Pharmacy, Lawrence & Memorial Hospital & Westerly Hospital “ASHP House of Delegates and the Policy Development Process”

10:00 am: RISHP Business Meeting followed by a Coffee Break and Exhibitor Display Visits

11:00 am: Christie Denton, PharmD & Renée Morin, PharmD, PGY1 Residents, South County Hospital, “Treatment with N-acetylcysteine in non-acetaminophen induced liver failure- a patient case study”

11:30 PM: Nishaminy Kasbekar, BS, PharmD, FASHP, Director of Pharmacy, Penn Presbyterian Medical Center & American Society of Health-System Pharmacists, “ASHP Update: National Perspective on Pharmacy Practice Advocacy”

12:15 pm: Ashley Rimay, PharmD, BCPS & Louis Palmisciano, Rhode Island Hospital, “Controlled Substance Diversion Prevention”

01:00 pm: Closing Remarks

Upon completion of this educational activity, pharmacists should be able to:

Rhode Island Hospital’s Approach to Improve Patient Safety and Optimize Pharmacy Services for Patients on Clinical Trials

1. Describe the unique risks associated with investigational drugs and clinical trial protocols
2. Identify opportunities for the pharmacist to support the medication use process for investigational drugs.
3. Give examples of strategies aimed to reduce risk of errors and improve patient safety in clinical trials.
4. Summarize the impact from the past year of adding dedicated pharmacists to oncology clinical trials  

Oral Compared to Intravenous Antibiotics for Preterm Pre-labor Rupture of Membranes

1. Discuss the pharmacologic interventions used in the management of preterm prelabor rupture of membranes.
2. Identify a potential rationale for the use of antibiotic therapy for preterm prelabor rupture of membranes.

New Career Trends for Pharmacy Technicians

1. Describe the purpose of the Pharmacy Technician Certification Board (PTCB)
2. Explain the functions of the PTCB in promoting patient safety
3. Identify the current role of the pharmacy technician
4. Summarize various specialized pharmacy technician positions
5. Describe the Compounded Sterile Preparation Technician (CSPT) Certification program
6. Discuss the upcoming Advanced Certified Pharmacy Technician Credential

ASHP House of Delegates and the Policy Development Process

1. Describe various stages of the American Society of Health System Pharmacists (ASHP) policy making process
2. Explain what happens at the Regional Delegate Conferences (RDC)
3. Summarize the results of the two policies that were voted on at the 2019 ASHP Summer Meeting

Treatment with N-acetylcysteine in non-acetaminophen induced liver failure- a patient case study

1. Recognize the pathophysiology and role of NAC in acute liver failure
2. Evaluate NAC’s appropriateness in patients with non-APAP induced liver failure

ASHP Update: National Perspective on Pharmacy Practice Advocacy

1. Discuss key trends shaping pharmacy practice
2. Discuss ASHP initiatives to meet today’s practice needs
3. Identify strategies and resultant resources for pharmacists and technicians.

Controlled Substance Diversion Prevention

1. Discuss opioid cases in the headlines
2. Review controlled substance laws
3. Describe controlled substance prescription monitoring
4. Summarize the approach to identifying potential vulnerabilities with Lifespan

Upon completion of this educational activity, pharmacy technicians should be able to:

Rhode Island Hospital's Approach to Improve Patient Safety and Optimize Pharmacy Services for Patients on Clinical Trials

1. Describe the unique risks associated with investigational drugs and clinical trial protocols
2. Identify opportunities for the pharmacist to support the medication use process for investigational drugs.
3. Give examples of strategies aimed to reduce risk of errors and improve patient safety in clinical trials.
4. Summarize the impact from the past year of adding dedicated pharmacists to oncology clinical trials  

Oral Compared to Intravenous Antibiotics for Preterm Pre-labor Rupture of Membranes

1. Define the term “latency antibiotics”.
2. Identify at least 2 maternal or fetal complications associated with preterm prelabor rupture of membranes.

New Career Trends for Pharmacy Technicians

1. Describe the purpose of the Pharmacy Technician Certification Board (PTCB)
2.  Explain the functions of the PTCB in promoting patient safety
3. Identify the current role of the pharmacy technician
4. Summarize various specialized pharmacy technician positions
5. Describe the Compounded Sterile Preparation Technician (CSPT) Certification program
6. Discuss the upcoming Advanced Certified Pharmacy Technician Credential

ASHP House of Delegates and the Policy Development Process

1. Describe various stages of the American Society of Health System Pharmacists (ASHP) policy making process
2. Explain what happens at the Regional Delegate Conferences (RDC)
3. Summarize the results of the two policies that were voted on at the 2019 ASHP Summer Meeting

Treatment with N-acetylcysteine in non-acetaminophen induced liver failure- a patient case study

1. Recognize the signs of acute liver failure
2. Explain the appropriateness of NAC in patients with non-APAP inducted liver failure

ASHP Update: National Perspective on Pharmacy Practice Advocacy

1. Discuss key trends shaping pharmacy practice
2. Discuss ASHP initiatives to meet today’s practice needs
3. Identify strategies and resultant resources for pharmacists and technicians.

Controlled Substance Diversion Prevention

1. Discuss opioid cases in the headlines
2. Review controlled substance laws
3. Describe controlled substance prescription monitoring
4. Summarize the approach to identifying potential vulnerabilities with Lifespan

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Attendance and completion of online program evaluations and self-assessment tools at the conclusion of the program are required in order to earn credit.

REQUIREMENTS FOR CE CREDIT

A program evaluation must be completed at www.uripharmacycpd.org within 60 days of the live program date in order to receive CE credit.  CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.

Financial support provided by the Rhode Island Society of Health-System Pharmacists

2.5 contact hours 0060-9999-19-054-L04-P 0060-9999-19-054-L04-T  
1.5 contact hours (Pharmacy Law) 0060-9999-19-055-L03-P  0060-9999-19-055-L03-T